Document
DailyMed Label: Halaven
Title
DailyMed Label: Halaven
Date
2023
Document type
DailyMed Prescription
Name
Halaven
Generic name
eribulin mesylate
Manufacturer
BSP Pharmaceuticals SpA
Product information
NDC: 43624-002
Product information
NDC: 43624-002
Product information
NDC: 43624-002
Package label
Eisai Manufacturing Limited
Allegato DQA-035/XXXX
New Chemical Entity Demand Chain Unit European Knowledge Centre
Mosquito Way-Hatfield, Herts, AL 109SN
United Kingdom
HALAVEN®
(eribulin mesylate) Injection, for intravenous use- 0.5mg/ml, 2 ml
Store at 15° - 25°C (59° - 77°F). DO NOT FREEZE
QTY: 00XXX EXP: MM-YYYY LOT: F1XXYZZZ
(22) 900XXX MMYYYY F1XXYZZZ 7
NDC 43624-002-01
( 0X) 50X XXXXX 00X X X0 XXX
Manufactured by : BSP Pharmaceuticals SpA-Latina Scalo, Italy.
Image (eribulin mesylate) Injection1 mg/2 mL(0.5 mg/mL)For Intravenous Use
2 organizations
2 products
Product
Eribulin mesylateOrganization
Eisai Inc.Product
EribulinOrganization
BSP Pharmaceuticals SpA